Effect of Kinesio Taping on Pain, Posture and Function in Lower Cross Syndrome

Effect of Kinesio Taping on Pain, Posture and Function in Patient With Lower Cross Syndrome

Determine the impact of Kinesio taping on pain, postural alignment and functional outcomes in individuals with lower cross syndrome.

Study Overview

• Status: Completed
• Conditions: Lower Cross Syndrome
• Intervention / Treatment: Other: Kinesio taping; Other: Conventional physical therapy

Detailed Description

Participants with lower cross syndrome who present to physical therapy department will be screened for eligibility on basis of inclusion and exclusion criteria. Group A will receive the treatment with moist hot pack along with stretching of tight erector spinae, hip flexors and strengthening of weak abdominals and gluteal muscles along with Kinesiotaping using inhibition and facilitation technique for LCS and Group B will receive the treatment with moist hot pack along with stretching of tight erector spinae, hip flexors and strengthening of weak abdominals and gluteal muscles. The patients will receive the treatment sessions 3 days per week for almost 04 weeks. They will be evaluated after the treatment for PAIN, POSTURAL ASSESSMENT, FUNCTIONAL DISABILITY in order to check for the effect of the treatment.

• Study Type: Interventional
• Enrollment (Actual): 44
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Pakistan
  • Punjab
    • Rawalpindi, Punjab, Pakistan, 46060
      • Railway hospital Rawalpindi

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• Age- 30 to 50 years.
• Female patients.
• Anterior pelvic tilting > 7-10 degrees.
• Postural imbalance characterized by anterior pelvic tilt, lumbar hyper lordosis, and associated muscle imbalances.
• Discomfort, pain, or limitations related to the lower back, pelvis, and hips attributed to LCS.
• Willing to provide informed consent to participate in the study.

Exclusion Criteria:

• Musculoskeletal pathologies affecting the lower back, pelvis, hips, or lower extremities (e.g., herniated disc, lumbar radiculopathy, lumbar stenosis, hip labral tear).
• Kinesiotaping interventions for LCS in the past 3 months.
• Allergies to tape materials or skin sensitivities that might prevent safe tape application.
• Pregnant individuals due to potential discomfort.
• Open wounds, infections, or skin conditions at the taping application site.
• Severe cardiovascular, pulmonary, renal, or neurological diseases.
• In other clinical trials involving interventions for LCS.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Double

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Kinesio taping along with conventional physical therapy; treatment with moist hot pack along with stretching of tight erector spinae, hip flexors and strengthening of weak abdominals and gluteal muscles along with Kinesiotaping using inhibition and facilitation technique for LCS.	Other: Kinesio taping; Kinesiotaping using inhibition technique in tight muscles and facilitation technique in weak muscles for LCS. Treatment sessions 3 days per week for almost 04 weeks. 10 mins moist hot pack; Stretching exercises of tight erector spinae, hip flexors 3-4 times a week 5 sec hold 5-7 reps 1 set.; Strengthening of weak abdominals and gluteal muscles 2-3 times in a week; Other: Conventional physical therapy; 10 mins moist hot pack; Stretching exercises of tight erector spinae, hip flexors 3-4 times a week 5 sec hold 5-7 reps 1 set.; Strengthening of weak abdominals and gluteal muscles 2-3 times in a week
Active Comparator: conventional physical therapy; Treatment with moist hot pack along with stretching of tight erector spinae, hip flexors and strengthening of weak abdominals and gluteal muscles.	Other: Conventional physical therapy; 10 mins moist hot pack; Stretching exercises of tight erector spinae, hip flexors 3-4 times a week 5 sec hold 5-7 reps 1 set.; Strengthening of weak abdominals and gluteal muscles 2-3 times in a week

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Visual analog scale (VAS)	To assess pain using a Visual Analog Scale (VAS), provide patient with a straight line ranging from "No Pain "to "Worst pain Imaginable "Ask patient to mark a point on line that represents their current pain intensity, with understanding that the left end means no pain, and the right end means the most severe pain imaginable, measure distance in millimeters from "No pain "end to the marked point to quantify the pain level. Pain is assess at the end of every week.	4th week
Anterior pelvic tilting	The hand-held pelvic inclinometer's is use for measure anterior pelvic tilting. Anterior pelvic tilting is measure at the end of every week.	4th week
Oswestry Disability Index (ODI)	The Oswestry Disability Index (ODI) is a widely used questionnaire to assess the functional disability and impact of lower back pain on an individual's daily life. Patients are asked to rate their level of disability on a scale from 0 to 5, with 0 indicating no disability and 5 indicating the highest level of disability. It is divided into ten sections that each target various tasks or functions. Higher percentages indicate greater disability. Functional disability through ODI assess after every 2nd week.	4th week
Muscle Length	The length of the bilateral Iliopsoas muscle was measured using a Universal Goniometer and the Modified Thomas test. A non-elastic measuring tape was used to examine the length of the spinal extensor muscle. Abdominal muscular strength and bilateral Gluteus maximus Manual muscle testing was graded according to the MRC grading system.	4th week

Collaborators and Investigators

• Sponsor: Riphah International University
• Investigators: Principal Investigator: Asmar Fatima, MS OMPT, Riphah International University

Study record dates

Study Major Dates

• Study Start (Actual): October 13, 2023
• Primary Completion (Actual): July 31, 2024
• Study Completion (Actual): August 30, 2024

Study Registration Dates

• First Submitted: March 4, 2024
• First Submitted That Met QC Criteria: March 4, 2024
• First Posted (Actual): March 12, 2024

Study Record Updates

• Last Update Posted (Actual): October 26, 2024
• Last Update Submitted That Met QC Criteria: October 23, 2024
• Last Verified: October 1, 2024

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Pathologic Processes; Disease; Syndrome
• Other Study ID Numbers: REC/MS-PT/01718 Nida Kausar

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No